• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients - indications for their potential involvement in t

tetano

Editor, Senior Moderator
Front Immunol


. 2022 Dec 13;13:1070994.
doi: 10.3389/fimmu.2022.1070994. eCollection 2022.
A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients - indications for their potential involvement in the development of Long COVID?


Simon Haunhorst[SUP] 1 [/SUP], Wilhelm Bloch[SUP] 2 [/SUP], Florian Javelle[SUP] 2 [/SUP], Karsten Krüger[SUP] 3 [/SUP], Sabine Baumgart[SUP] 4 [/SUP], Sebastian Drube[SUP] 4 [/SUP], Christina Lemhöfer[SUP] 5 [/SUP], Philipp Reuken[SUP] 6 [/SUP], Andreas Stallmach[SUP] 6 7 [/SUP], Michael Müller[SUP] 8 [/SUP], Christina E Zielinski[SUP] 8 [/SUP], Mathias W Pletz[SUP] 4 7 9 [/SUP], Holger H W Gabriel[SUP] 1 [/SUP], Christian Puta[SUP] 1 7 10 [/SUP]



Affiliations

Abstract

Background: Recovery from coronavirus disease 2019 (COVID-19) can be impaired by the persistence of symptoms or new-onset health complications, commonly referred to as Long COVID. In a subset of patients, Long COVID is associated with immune system perturbations of unknown etiology, which could be related to compromised immunoregulatory mechanisms.
Objective: The objective of this scoping review was to summarize the existing literature regarding the frequency and functionality of Tregs in convalescent COVID-19 patients and to explore indications for their potential involvement in the development of Long COVID.
Design: A systematic search of studies investigating Tregs during COVID-19 convalescence was conducted on MEDLINE (via Pubmed) and Web of Science.
Results: The literature search yielded 17 relevant studies, of which three included a distinct cohort of patients with Long COVID. The reviewed studies suggest that the Treg population of COVID-19 patients can reconstitute quantitatively and functionally during recovery. However, the comparison between recovered and seronegative controls revealed that an infection-induced dysregulation of the Treg compartment can be sustained for at least several months. The small number of studies investigating Tregs in Long COVID allowed no firm conclusions to be drawn about their involvement in the syndrome's etiology. Yet, even almost one year post-infection Long COVID patients exhibit significantly altered proportions of Tregs within the CD4+ T cell population.
Conclusions: Persistent alterations in cell frequency in Long COVID patients indicate that Treg dysregulation might be linked to immune system-associated sequelae. Future studies should aim to address the association of Treg adaptations with different symptom clusters and blood parameters beyond the sole quantification of cell frequencies while adhering to consensualized phenotyping strategies.

Keywords: COVID-19; Long Covid; SARS-CoV-2; adaptive immunity; immune system; regulatory T cells (T reg).
 
Back
Top Bottom